To test the effects of CTSD inhibition in NASH-associated dyslipidemia, Ldlr-/- mice on HFC diet were injected with either control or intra- or extracellular CTSD inhibitors for a period of 10 weeks. Here, CTSD is linked to metabolic dysfunction-associated steatohepatitis.